Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

82.46
-0.1500-0.18%
Post-market: 82.18-0.2800-0.34%17:51 EDT
Volume:4.03M
Turnover:333.86M
Market Cap:47.85B
PE:45.06
High:83.62
Open:82.43
Low:81.73
Close:82.61
52wk High:87.89
52wk Low:65.94
Shares:580.30M
Float Shares:574.00M
Volume Ratio:0.92
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.83
EPS(LYR):1.83
ROE:10.35%
ROA:7.65%
PB:4.63
PE(LYR):44.99

Loading ...

Edwards Lifesciences price target raised to $95 from $92 at UBS

TIPRANKS
·
Jan 12

Baird Adjusts Price Target on Edwards Lifesciences to $90 From $87, Maintains Neutral Rating

MT Newswires Live
·
Jan 12

Barclays Reaffirms Their Buy Rating on Edwards Lifesciences (EW)

TIPRANKS
·
Jan 12

Elbit Systems Awarded $275 Million, 5-Year Contracts for Advanced EW, DIRCM Services

MT Newswires Live
·
Jan 12

Edwards Lifesciences Stock (EW) Falls as FTC Wins Ruling to Block JenaValve Deal

TIPRANKS
·
Jan 11

Edwards Lifesciences will not acquire JenaValve, updates FY26 guidance

TIPRANKS
·
Jan 10

Edwards Lifesciences raises FY26 adjusted EPS view to $2.90-$3.05

TIPRANKS
·
Jan 10

Edwards Lifesciences Drops Merger With JenaValve

Dow Jones
·
Jan 10

BRIEF-Edwards Says Co Will Not Acquire Jenavalve

Reuters
·
Jan 10

Edwards Lifesciences Corp - Revises 2026 EPS Guidance to $2.90-$3.05

THOMSON REUTERS
·
Jan 10

Edwards Comments on Jenavalve Acquisition

THOMSON REUTERS
·
Jan 10

Daniel J. Lippis, CVP TAVR, reports disposal of Edwards Lifesciences Corporation common shares

Reuters
·
Jan 10

Judge Grants U.S. Federal Trade Commission Request to Block Edwards Lifesciences Corp's Acquisition of Jenavalve Technology Inc -- Court Records

THOMSON REUTERS
·
Jan 10

FTC wins ruling blocking Edwards Lifesciences' acquisition of JenaValve

Reuters
·
Jan 10

Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $108 From $104, Maintains Buy Rating

MT Newswires Live
·
Jan 09

Edwards Lifesciences Corp : TD Cowen Raises to Buy From Hold; Raises Target Price to $97 From $90

THOMSON REUTERS
·
Jan 09

Edwards Lifesciences upgraded to Buy from Hold at TD Cowen

TIPRANKS
·
Jan 09

Edwards Lifesciences price target raised to $108 from $104 at Goldman Sachs

TIPRANKS
·
Jan 09

RBC Capital Remains a Buy on Edwards Lifesciences (EW)

TIPRANKS
·
Jan 09

Donald E. Bobo Jr., CVP of Strategy/Corp Development, Reports Disposal of Edwards Lifesciences Common Shares

Reuters
·
Jan 07